Bipolar Disorder
📧 Sign up to get email alerts when something new happens for Bipolar Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2018-03-06FDA Approved: DEPAKOTE ER — Supplemental Application (AbbVie Inc.)
The FDA approved a supplemental application for Depakote ER (divalproex sodium) from AbbVie, authorizing changes to its labeling.
-
CLINICAL_TRIALS trial_result · 2018-03-01Clinical Trial Update: Exercise for Depression [NA]
A completed clinical trial evaluating exercise as a treatment for depression, including major depressive disorder and bipolar disorder, cond…
-
CLINICAL_TRIALS trial_result · 2018-02-22Clinical Trial Update: Allopurinol Maintenance Study for Bipolar Disorder [Phase 4]
A Phase 4 clinical trial evaluating maintenance allopurinol for bipolar disorder has been terminated; results were posted in 2018.
-
EMA safety_alert · 2018-02-09PRAC recommends new measures to avoid valproate exposure in pregnancy
The PRAC recommends new measures to prevent valproate exposure during pregnancy due to risks of birth defects and developmental problems in …
-
CLINICAL_TRIALS withdrawal · 2018-02-09Clinical Trial Update: Neural Correlates for Therapeutic Mechanisms of Lithium in Bipolar Disorder [Phase 4]
A Phase 4 trial evaluating neural correlates for therapeutic mechanisms of lithium in bipolar disorder has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2018-01-29FDA Approved: LAMOTRIGINE KIT — Supplemental Application (OWP Pharmaceuticals, Inc.)
FDA approved a supplemental application for Lamotrigine Kit from OWP Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2018-01-24Clinical Trial Update: Citicoline for Bipolar 1 Disorder and Cocaine Dependence [Phase 4]
Phase 4 trial investigating citicoline for Bipolar 1 Disorder and cocaine dependence; study completed with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-01-18Clinical Trial Update: Drug Treatment for Alcoholics With Bipolar Disorder [Phase 2]
Phase 2 trial update for a drug treatment targeting individuals with alcoholism and bipolar disorder; study completed.
-
FDA approval · 2017-12-29FDA Approved: LAMOTRIGINE — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approves Alembic Pharmaceuticals Limited's supplemental application for lamotrigine chewable dispersible, expanding the approved generic…
-
FDA approval · 2017-12-11FDA Approved: ARIPIPRAZOLE — Original Application (Bionpharma Inc.)
FDA approved Bionpharma's ARIPIPRAZOLE as an original application generic, allowing marketing for the same indications as the reference prod…
-
CLINICAL_TRIALS trial_result · 2017-12-08Clinical Trial Update: Implementation Trial of Evidence Based Practices for Mood Disorders [NA]
Completion of an implementation trial evaluating evidence-based practices for mood disorders, including bipolar disorder and treatment-resis…
-
CLINICAL_TRIALS trial_result · 2017-12-06Clinical Trial Update: Peer Support for Increasing Physical Activity in People With Serious Mental Illnesses [NA]
This ClinicalTrials.gov update indicates that the Johns Hopkins University-sponsored trial 'Peer Support for Increasing Physical Activity in…
-
FDA approval · 2017-12-04FDA Approved: ARIPIPRAZOLE — Original Application (Solco Healthcare U.S., LLC)
FDA approved ARIPIPRAZOLE from Solco Healthcare U.S., LLC as an original generic application. The approval allows generic aripiprazole for t…
-
FDA approval · 2017-11-29FDA Approved: QUETIAPINE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved Macleods Pharmaceuticals Limited's generic quetiapine under an Original Application (ANDA204253), making a generic version of q…
-
FDA approval · 2017-11-29FDA Approved: QUETIAPINE FUMARATE — Original Application (Accord Healthcare Inc.)
FDA approved a generic quetiapine fumarate product from Accord Healthcare Inc. under an original ANDA.
-
FDA approval · 2017-11-29FDA Approved: QUETIAPINE FUMARATE — Original Application (Ingenus Pharmaceuticals, LLC)
FDA approves Ingenus Pharmaceuticals' quetiapine fumarate under an Original Application, making a generic version of the antipsychotic avail…
-
FDA approval · 2017-11-29FDA Approved: QUETIAPINE FUMARATE — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for a generic quetiapine fumarate product from Aurobindo Pharma Limited. Quetiapine is used to treat s…
-
FDA approval · 2017-11-29FDA Approved: QUETIAPINE EXTENDED RELEASE — Original Application (ACI Healthcare USA, Inc.)
FDA approved an original application for quetiapine extended-release (generic) by ACI Healthcare USA, Inc., making a generic version of quet…
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Task Sharing for the Care of Severe Mental Disorders in a Low-income Country [Phase 3]
A Phase 3 trial evaluating a task-sharing care model for schizophrenia, bipolar disorder, major depressive disorder, and schizoaffective dis…
-
CLINICAL_TRIALS research · 2017-11-27Clinical Trial Update: A Study of Aerobic Exercise for Patients With Bipolar Disorder [NA]
This entry reports a clinical trial evaluating aerobic exercise for bipolar disorder with cognitive symptoms, sponsored by Guangzhou Psychia…
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: Iloperidone in Mixed States of Bipolar Disorder [Phase 4]
Phase 4 trial update for iloperidone in mixed states of bipolar disorder has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-10-31Clinical Trial Update: Long-term Study of FK949E in Elderly Bipolar Disorder Patients [Phase 3]
Phase 3 long-term study of FK949E in elderly patients with bipolar disorder has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2017-10-30Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of Repeat Doses of GSK1014802. [Phase 1]
Phase 1 clinical trial update shows safety, tolerability, and pharmacokinetics of repeat doses of GSK1014802. The study has completed in par…
-
CLINICAL_TRIALS trial_result · 2017-10-26Clinical Trial Update: GSK Drug Single Dose Escalation And Their Effect On Resting Motor Threshold In Healthy Volunteers [Phase 1]
Phase 1 study evaluating a GlaxoSmithKline drug given as a single dose to healthy volunteers and its effect on resting motor threshold; the …
-
CLINICAL_TRIALS research · 2017-10-26Clinical Trial Update: Joint Crisis Plans or Crisis Cards for People With Severe Mental Disorders to Reduce Coercion in Psychiatric Care. [NA]
This clinical trial evaluates the use of joint crisis plans or crisis cards to reduce coercion in psychiatric care for people with schizophr…